CCA Longevity Fund V (US) LLC
Raised
Pre-open
Investors
—
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
CCA Longevity Fund V (US) LLC is a Delaware pooled investment fund filed under Rule 506(b) and 3(c) exemptions. This is an amended filing with pre-open status; no capital raised, investor count, or minimum investment has been disclosed. William Corry is listed as director.
This longevity biotech fund utilizes the 506(b) private placement exemption typical for institutional venture funds, allowing general solicitation restrictions in exchange for flexibility on investor accreditation verification. The pre-open amended filing pattern suggests organizational or structural updates prior to formal capital deployment, common in the venture fund lifecycle.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
William Corry
Director · Vero Beach, FL
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
